risedronate

(redirected from Atelvia)
Also found in: Medical.

ri·sed·ro·nate

 (rĭ-sĕd′rə-nāt′)
n.
A bisphosphonate drug, C7H11NO7P2, that inhibits bone resorption and is used in the form of its sodium salt to treat and prevent osteoporosis in postmenopausal women.

[Perhaps (py)ri(dine) + -se-, origin unknown + (hy)dr(oxy) + (bisphosph)onate.]
Translations

risedronate, risedronate sodium

(USAN), risedronic acid (INN) n risedronato, risedronato sódico, ácido risedrónico (INN)
References in periodicals archive ?
Norethindrone acetate/ethinyl estradiol, the generic version of Lo Loestrin Fe; and risedronate sodium, the generic version of Atelvia, are awaiting regulatory approvals.
The approval comes after Actavis agreed to sell rights and assets related to generic versions of Femcon FE, Loestrin 24 FE, Lo Loestrin FE and Atelvia to Amneal Pharmaceuticals.
(12) A delayed release form of risedronate (Atelvia) has been approved for the treatment of postmenopausal osteoporosis.
Other bisphosphonate drugs that were not tested in the study include risedronate (Actonel, Atelvia), alendronate (Fosamax), and iban-dronate (Boniva).
A new delayed-release formulation of risedronate (Atelvia) was approved by the FDA in late 2010 and made available for prescribing earlier this year.
The drugs include oral forms--alendronate (Fosamax) and risedronate (Actonel, Atelvia)--and injectable forms--ibandronate (Boniva) and zoledronic acid (Reclast).
These include Fosamax, Fosamax Plus D, Actonel, Actonel with Calcium, Boniva, Atelvia, and Reclast, and their generics.
The drugs affected are Actonel; Actonel Plus Calcium; Atelvia; Boniva; Fosamax; Fosamax Plus D; and Reclast, as well as their generic offspring.
The products affected are those approved for osteoporosis indications, such as alendronate (Fosamax), alendronate and cholecalciferol (Fosamax Plus D), risedronate sodium (Actonel), risedronate sodium with calcium carbonate (Actonel with Calcium), ibandronate sodium (Boniva), risedronate sodium (Atelvia), pamidronate injection (Aredia), and zoledronic acid injection (Reclast), as well as generic formulations of those drugs.